首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
cardiorenal syndrome type Ⅱ相关文献:
Cardiorenal syndrome.
Ronco C, Haapio M, House AA, Anavekar N, Bellomo R.
J Am Coll Cardiol. 2008 Nov 4;52(19):1527-39. doi: 10.1016/j.jacc.2008.07.051.
PMID:19007588
Cardiorenal syndrome.
Ronco C, Di Lullo L.
Heart Fail Clin. 2014 Apr;10(2):251-80. doi: 10.1016/j.hfc.2013.12.003. Epub 2014 Feb 4.
PMID:24656104
Heart Failure and Cardiorenal Syndrome: A Narrative Review on Pathophysiology, Diagnostic and Therapeutic Regimens-From a Cardiologist's View.
Mitsas AC, Elzawawi M, Mavrogeni S, Boekels M, Khan A, Eldawy M, Stamatakis I, Kouris D, Daboul B, Gunkel O, Bigalke B, van Gisteren L, Almaghrabi S, Noutsias M.
J Clin Med. 2022 Nov 28;11(23):7041. doi: 10.3390/jcm11237041.
PMID:36498617
Wnt/beta-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome.
Zhao Y, Wang C, Hong X, Miao J, Liao Y, Hou FF, Zhou L, Liu Y.
Kidney Int. 2019 Apr;95(4):815-829. doi: 10.1016/j.kint.2018.11.021. Epub 2019 Feb 12.
PMID:30770217
[Cardiorenal syndrome: classification, pathophysiology, diagnosis and management. Literature review].
Chávez-Iñiguez JS, Sánchez-Villaseca SJ, García-Macías LA.
Arch Cardiol Mex. 2022 Apr 4;92(2):253-263. doi: 10.24875/ACM.20000183.
PMID:34261129
Gualou xiebai decoction ameliorates cardiorenal syndrome type II by regulation of PI3K/AKT/NF-kappaB signalling pathway.
Wang YY, Liu YY, Li J, Zhang YY, Ding YF, Peng YR.
Phytomedicine. 2024 Jan;123:155172. doi: 10.1016/j.phymed.2023.155172. Epub 2023 Oct 30.
PMID:37976694
Type 4 cardiorenal syndrome.
Pinheiro da Silva AL, Vaz da Silva MJ.
Rev Port Cardiol. 2016 Nov;35(11):601-616. doi: 10.1016/j.repc.2016.06.007. Epub 2016 Oct 4.
PMID:27712930
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors.
Salvatore T, Galiero R, Caturano A, Rinaldi L, Di Martino A, Albanese G, Di Salvo J, Epifani R, Marfella R, Docimo G, Lettieri M, Sardu C, Sasso FC.
Int J Mol Sci. 2022 Mar 26;23(7):3651. doi: 10.3390/ijms23073651.
PMID:35409011
The cardio-renal-metabolic connection: a review of the evidence.
Marassi M, Fadini GP.
Cardiovasc Diabetol. 2023 Jul 31;22(1):195. doi: 10.1186/s12933-023-01937-x.
PMID:37525273
Experimental Cardiorenal Syndrome Type 3: What Is Known so Far?
Patschan D, Marahrens B, Jansch M, Patschan S, Ritter O.
J Clin Med Res. 2022 Jan;14(1):22-27. doi: 10.14740/jocmr4639. Epub 2022 Jan 29.
PMID:35211213
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3